The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Positive effect of CPAP therapy in OSA patients on A-FABP, CRP and triacylglycerols levels and diastolic blood pressure Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Long-term continuous positive airway pressure (nCPAP) treatment maintains the improvement of insulin sensitivity in patients with OSAS after 2.8 years Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Plasma endothelin-1 (ET-1) levels in obstructive sleep apnea (OSA) patients and effect of continouous positive airway pressure (CPAP) treatment Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005
Elevated serum erythropoietin level in obesity hypoventilation syndrome patients improved by nasal positive pressure ventilation therapy Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002
Serum vitamin D levels in patients with obstructive sleep apnea syndrome and concentration changes after continuous positive airway pressure treatment Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020
Continuous positive airway pressure treatment associates with decreasing glycosylated hemoglobin (HbA1 c) even in euglycemic obstructive sleep apnoea patients within normal HbA1 c range Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in patients with OSAS with emphasis on gender differences Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Positive airway pressure treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients: Longitudinal data from the ESADA Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019
Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004
Higher serum lactic deydrogenase (LDH) levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure (CPAP) Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004
Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP Source: Eur Respir J 2007; 30: 496-500 Year: 2007
Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004
Effect of 3-month CPAP treatment on blood pressure and serum aldosterone concentration in patients with resistant hypertension Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Standard continuous positive airway pressure (CPAP) Source: Annual Congress 2007 - Practical workshop: continuous positive airway pressure (CPAP) Year: 2007
Effect of automatic positive airway pressure (APAP) therapy on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and hypertension Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008
CPAP decreases elevated plasma levels of soluble tumor necrosis factor-α receptor 1 in OSAS patients Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008